Tout DSpace

Afficher la notice abrégée

Determinants of cancer immunotherapy success

dc.creatorKaranikas, V.en
dc.creatorGermenis, A.en
dc.date.accessioned2015-11-23T10:33:20Z
dc.date.available2015-11-23T10:33:20Z
dc.date.issued2010
dc.identifier10.1586/erv.10.138
dc.identifier.issn1476-0584
dc.identifier.urihttp://hdl.handle.net/11615/29047
dc.source.uri<Go to ISI>://WOS:000285487200003
dc.subjectcytolytic T lymphocytesen
dc.subjectimmunotherapyen
dc.subjectpre-existing anti-tumor-specificen
dc.subjectCTLen
dc.subjectEX-VIVO CHARACTERIZATIONen
dc.subjectT-CELL RESPONSESen
dc.subjectLUNG-CANCERen
dc.subjectIMMUNOLOGICALen
dc.subjectEVALUATIONen
dc.subjectPEPTIDE VACCINATIONen
dc.subjectIMMUNOSENESCENCEen
dc.subjectLYMPHOCYTESen
dc.subjectFREQUENCYen
dc.subjectMELANOMAen
dc.subjectINDIVIDUALSen
dc.subjectImmunologyen
dc.titleDeterminants of cancer immunotherapy successen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée